{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:11:39Z","timestamp":1792192299411,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89760-0","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T08:42:25Z","timestamp":1741164145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroko","family":"Miyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Peak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasreman","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Yoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Marchion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Moran Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Roman Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Zemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Chahoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"89760_CR1","unstructured":"Key Statistics for Bladder Cancer. https:\/\/www.cancer.org\/cancer\/types\/bladder-cancer\/about\/key-statistics.html Accessed March 12, 2024."},{"key":"89760_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","volume":"19","author":"VB Joshi","year":"2022","unstructured":"Joshi, V. B., Spiess, P. E., Necchi, A., Pettaway, C. A. & Chahoud, J. Immune-based therapies in penile cancer. Nat. Rev. Urol. 19, 457\u2013474 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"89760_CR3","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.3390\/cancers14246024","volume":"14","author":"J Chahoud","year":"2022","unstructured":"Chahoud, J. et al. Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: Results of 5 years follow-up. Cancers 14, 6024 (2022).","journal-title":"Cancers"},{"key":"89760_CR4","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3390\/cancers15143713","volume":"15","author":"K Parza","year":"2023","unstructured":"Parza, K. et al. The prognostic role of human papillomavirus and p16 status in penile squamous cell carcinoma-a systematic review. Cancers 15, 3713 (2023).","journal-title":"Cancers"},{"key":"89760_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/cancers16020303","volume":"16","author":"F Ionescu","year":"2024","unstructured":"Ionescu, F. et al. Multiplex immunofluorescence captures progressive immune exhaustion with advancing penile squamous cell cancer stage. Cancers 16, 303 (2024).","journal-title":"Cancers"},{"key":"89760_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2020.05.033","volume":"78","author":"A Thomas","year":"2020","unstructured":"Thomas, A. et al. Establishment, characterization, and imaging of a first platinum-resistant penile cancer patient-derived xenograft in nude mice: A eUROGEN project. Eur. Urol. 78, 294\u2013296 (2020).","journal-title":"Eur. Urol."},{"key":"89760_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"89760_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41467-023-37353-8","volume":"14","author":"I Nofech-Mozes","year":"2023","unstructured":"Nofech-Mozes, I., Soave, D., Awadalla, P. & Abelson, S. Pan-cancer classification of single cells in the tumour microenvironment. Nat. Commun. 14, 1615 (2023).","journal-title":"Nat. Commun."},{"key":"89760_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","volume":"86","author":"L Elst","year":"2024","unstructured":"Elst, L. et al. Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur. Urol. 86, 114\u2013127 (2024).","journal-title":"Eur. Urol."},{"issue":"2","key":"89760_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.eururo.2024.04.032","volume":"86","author":"J Chahoud","year":"2024","unstructured":"Chahoud, J., Xiaoqing, Y., Necchi, A. & Spiess, P. E. TP53 mutations emerge as a critical biomarker in penile cancer, superseding human papillomavirus status. Eur. Urol. 86(2), 128\u2013129. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.032 (2024).","journal-title":"Eur. Urol."},{"key":"89760_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442-459.e429 (2020).","journal-title":"Cell"},{"key":"89760_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"89760_CR13","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of infiltrating t cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342-1356.e1316 (2017).","journal-title":"Cell"},{"key":"89760_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell 42, 815-832.e812 (2024).","journal-title":"Cancer Cell"},{"key":"89760_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","volume":"39","author":"DA Braun","year":"2021","unstructured":"Braun, D. A. et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 39, 632-648.e638 (2021).","journal-title":"Cancer Cell"},{"key":"89760_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"89760_CR17","doi-asserted-by":"publisher","first-page":"1838141","DOI":"10.1080\/2162402X.2020.1838141","volume":"9","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response. Oncoimmunology 9, 1838141 (2020).","journal-title":"Oncoimmunology"},{"key":"89760_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.csbj.2021.01.025","volume":"19","author":"JW Cho","year":"2021","unstructured":"Cho, J. W., Son, J., Ha, S. J. & Lee, I. Systems biology analysis identifies TNFRSF9 as a functional marker of tumor-infiltrating regulatory T-cell enabling clinical outcome prediction in lung cancer. Comput. Struct. Biotechnol. J. 19, 860\u2013868 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"89760_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114073","volume":"43","author":"CE Moss","year":"2024","unstructured":"Moss, C. E. et al. Aging-related defects in macrophage function are driven by MYC and USF1 transcriptional programs. Cell Rep. 43, 114073 (2024).","journal-title":"Cell Rep."},{"key":"89760_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.immuni.2023.01.011","volume":"56","author":"SK Wculek","year":"2023","unstructured":"Wculek, S. K. et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity 56, 516-530.e519 (2023).","journal-title":"Immunity"},{"key":"89760_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/jnci\/djad155","volume":"115","author":"T El Zarif","year":"2023","unstructured":"El Zarif, T. et al. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: Report from the Global Society of Rare Genitourinary Tumors. J. Natl. Cancer Inst. 115, 1605\u20131615 (2023).","journal-title":"J. Natl. Cancer Inst."},{"key":"89760_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma, R. Y., Black, A. & Qian, B. Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563 (2022).","journal-title":"Trends Immunol."},{"key":"89760_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660944","volume":"12","author":"N Bannoud","year":"2021","unstructured":"Bannoud, N. et al. Hypoxia supports differentiation of terminally exhausted CD8 T cells. Front. Immunol. 12, 660944 (2021).","journal-title":"Front. Immunol."},{"key":"89760_CR24","doi-asserted-by":"publisher","first-page":"1084887","DOI":"10.3389\/fimmu.2023.1084887","volume":"14","author":"A Tiwari","year":"2023","unstructured":"Tiwari, A. et al. Towards a consensus definition of immune exclusion in cancer. Front. Immunol. 14, 1084887 (2023).","journal-title":"Front. Immunol."},{"key":"89760_CR25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/cancers12071796","volume":"12","author":"C Chu","year":"2020","unstructured":"Chu, C. et al. Immunophenotypes based on the tumor immune microenvironment allow for unsupervised penile cancer patient stratification. Cancers 12, 1796 (2020).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89760-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89760-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89760-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T20:15:31Z","timestamp":1741205731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89760-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89760"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89760-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P E Spiess reports the following leadership positions: President of Global Society of Rare GU Tumors, NCCN bladder and penile cancer panel, vice-chair, Member of ASCO\/EAU Penile Cancer Panel.   J Chahoud received consultation fees from Pfizer, Aveo, Eisai, Merck, Exelixis and mycaregorythm. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7703"}}